Positive Phase 3 topline results demonstrating envudeucitinib’s leading skin clearance, meaningful symptom improvement and a favorable safety ...
SRINAGAR: Jammu-based lawyer Deepika Pushkar Nath, who represented the family of the eight-year-old victim in the 2018 Kathua ...
Johnson & Johnson JNJ rapidly advanced its pipeline in 2025, attaining significant clinical and regulatory milestones that will help drive growth through the back half of the decade. In 2025, it ...
Kevin West (R‑Moore) and Rick West (R‑Heavener), asks the Oklahoma Supreme Court to overturn Oklahoma Corporation Commission orders that signed off on about $1.5 billion in 2023 costs: roughly $530 ...
Out Thursday ...
T he recent reimbursement of Bimzelx (bimekizumab) in Ireland represents an important step forward in access to treatment for people living with immune-mediated diseases, includin ...
In 2025 Pearson raced with Nielsen in the EuroFormula Open Championship, finishing fifth overall with wins in Portimao and ...
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for moderate-to-severe plaque psoriasis in adults and pediatric ...
Pearson and Tata Consultancy Services have formed a multi-year partnership to help enterprises develop future-ready workforces by combining AI-powered learning, assessment, and cloud-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results